E-cadherin and α-, β-, and γ-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions

Journal of Pathology

Volumn 192, Issue 4, 2000, Pages 460-469

  Davidson, Ben ^a   Berner, Aasmund ^a   Nesland, Jahn M ^a   Risberg, Bjorn ^a   Berner, Heidi S ^a   Trope, Claes G ^a   Kristensen, Gunnar B ^a   Bryne, Magne ^a,b   Florenes, Vivi Ann ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

, , and catenin; Calretinin; E cadherin; Immunoblotting; Immunocytochemistry; Ovarian carcinoma; Serous effusions

Indexed keywords

ALPHA CATENIN; BETA CATENIN; CALRETININ; CELL MARKER; PLAKOGLOBIN; UNCLASSIFIED DRUG; UVOMORULIN;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTODIAGNOSIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; EFFUSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MESOTHELIUM CELL; METASTASIS; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; STAINING; TUMOR BIOPSY;

ALPHA CATENIN; ASCITIC FLUID; BETA CATENIN; CADHERINS; CYTOSKELETAL PROTEINS; DESMOPLAKINS; FEMALE; GAMMA CATENIN; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM METASTASIS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PLEURAL EFFUSION, MALIGNANT; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 0033675418     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH726>3.0.CO;2-M     Document Type: Article

References (57)

1. Global cancer statistics
2. Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1954 and 1993
3. International Federation Gynecology and Obstetrics: Annual Report on the Results of Treatment in Gynecological Cancer
4. Symptomatology of ovarian cancer
5. Ovarian cancer stages I and II: Predictions and 5-year survival in two decades
6. Diagnostic problems in serous effusions
7. Stage IV ovarian cancer: Impact of surgical debulking
8. Role of cytoreductive surgical treatment in the management of advanced ovarian cancer
9. The cadherins: Cell-cell adhesion molecules controlling animal morphogenesis
10. Cadherin cell adhesion molecules with distinct binding specificities share a common structure
11. Cadherin cell adhesion receptors as a morphogenetic regulator
12. The structural and functional analysis of cadherin calcium-dependent cell adhesion molecules
13. Cadherins and catenins: Role in signal transduction and tumor progression
14. E-cadherin mediated adhesion system in cancer cells
15. E-cadherin and α-, β- and γ-catenin protein expression in relation to metastasis in human breast carcinoma
16. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers
17. The oncogenic activation of β-catenin
18. Regulation of LEF-1/TCT transcription factors by Writ and other signals
19. The role of beta-catenin in cell adhesion, signal transduction, and cancer
20. The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancer
21. E-cadherin expression in human epithelial ovarian cancer and normal ovary
22. Increased E-cadherin expression in ovarian surface epithelium. An early step in metaplasia and dysplasia?
23. Expression of E-cadherin in normal, benign, and malignant tissues of the female genital organs
24. Expression of E-cadherin, α-catenin and β-catenin in normal ovarian surface epithelium and epithelial ovarian cancers
25. Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors
26. Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: A clinicopathologic study of 60 cases
27. Clinical significance of α-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer
28. Expression of E-cadherin and α- and β-catenin mRNAs in ovarian cancers
29. Mutations of the E-cadherin gene in human gynecologic cancers
30. Mutations in the β-catenin gene (CTNNBI) in the endometrioid ovarian carcinomas
31. β-catenin mutation and expression analysis in ovarian cancer: Exon 3 mutations and nuclear translocation in 16% of endometrioid tumours
32. β-catenin expression pattern in stage I and II ovarian carcinomas. Relationship with β-catenin gene mutations, clinicopathological features, and clinical outcome
33. Mutational analysis of β-catenin gene in Japanese ovarian carcinomas: Frequent mutations in endometrioid carcinomas
34. Calretinin: A novel immunocytochemical marker for mesothelioma
35. Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma
36. Malignant Effusions: A Multimodal Approach to Cytologic Diagnosis
37. Detection of cancer cells in effusions from patients diagnosed with gynecological malignancies - Evaluation of five epithelial markers
38. Surface epithelial-stromal tumors
39. Differential expression of cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells
40. E-cadherin, N-cdherin, and calretinin in pleural effusions: The good, the bad, the worthless
41. The cell adhesion molecule, E-cadherin, distinguishes mesothelial cells from carcinoma cells in fluids
42. Altered expression of E-cadherin in gastric cancer tissues and carcinomatous fluid
43. Mutations of the human E-cadherin (CDHI) gene
44. Identification and purification of a cell surface glycoprotein mediating intercellular adhesion in embryonic and adult tissue
45. Inhibition of adhesion and induction of epithelial cell invasion by HAV-containing E-cadherin specific peptides
46. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serious effusions from patients diagnosed with epithelial ovarian carcinoma - Evidence of up-regulated Tn and Sialyl Tn antigens expression in effusions
47. Unstable expression of E-cadherin adhesion molecules in metastatic ovarian tumor cells
48. Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer
49. Re-expression of E-cadherin, α-catenin and β-catenin, but not γ-catenin, in metastatic tissue from breast cancer patients
50. Cancer metastasis: Negative regulation by an invasion-suppressor complex
51. E-cadherin expression determines the mode of replacement of normal urothelium by human bladder carcinoma cells
52. E-cadherin promotes intraepithelial expansion of bladder carcinoma cells in an in vitro model of carcinoma in situ
53. Putative mechanism through which N-cadherin-mediated cell contact maintains calcium homeostasis and thereby prevents ovarian cells from undergoing apoptosis
54. E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells
55. In vivo analysis of cadherin function in the mouse intestinal epithelium: Essential roles in adhesion, maintenance of differentiation, and regulation of programmed cell death
56. Adhesion molecule expression in breast cancer: The phoenix in tumour metastasis?
57. E-cadherin complex protein expression and survival in ovarian carcinoma